Predicting the clinical behavior of ovarian cancer from gene expression profiles-Reference-Cited by-同舟云学术

Predicting the clinical behavior of ovarian cancer from gene expression profiles

Published:2006-02 Issue:S1 Volume:16 Page:147-151
ISSN:1048-891X
Container-title:International Journal of Gynecological Cancer
language:en
Short-container-title:

Author:

DE SMET F.,POCHET N.L.M.M.,ENGELEN K.,VAN GORP T.,VAN HUMMELEN P.,MARCHAL K.,AMANT F.,TIMMERMAN D.,DE MOOR B.L.R.,VERGOTE I.B.

Publisher

BMJ

Subject

Obstetrics and Gynecology,Oncology

Reference19 articles.

1. Impact of adjuvant chemotherapy and surgical staging in early-stage ovarian carcinoma: European Organisation for Research and Treatment of Cancer-Adjuvant ChemoTherapy in Ovarian Neoplasm trial;Trimbos;J Natl Cancer Inst,2003

2. Second-line platinum therapy in patients with ovarian cancer previously treated with cisplatin;Markman;J Clin Oncol,1991

3. Prediction of optimal versus suboptimal cytoreduction of advanced-stage serous ovarian cancer with the use of microarrays;Berchuck;Am J Obstet Gynecol,2004

4. Gene expression in ovarian cancer reflects both morphology and biological behavior, distinguishing clear cell from other poor-prognosis ovarian carcinomas;Schwartz;Cancer Res,2002

5. Gene expression patterns that characterize advanced stage serous ovarian cancers;Lancaster;J Soc Gynecol Investig,2004

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Identifying a miRNA signature for predicting the stage of breast cancer;Scientific Reports;2018-10-31

2. Pharmacogenomics in epithelial ovarian cancer first-line treatment outcome: validation of GWAS-associated NRG3 rs1649942 and BRE rs7572644 variants in an independent cohort;The Pharmacogenomics Journal;2018-10-05

3. Ubiquitin–Proteasome Axis, Especially Ubiquitin-Specific Protease-17 (USP17) Gene Family, is a Potential Target for Epithelial–Mesenchymal Transition in High-Grade Serous Ovarian Cancer;Reproductive Sciences;2018-09-09

4. Prediction of resistance to chemotherapy in ovarian cancer: a systematic review;BMC Cancer;2015-03-11

5. Angiogenic mRNA and microRNA Gene Expression Signature Predicts a Novel Subtype of Serous Ovarian Cancer;PLoS ONE;2012-02-13